Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Buy Rating on Eastman Chemical with Positive Outlook

Elaine Mendonca by Elaine Mendonca
February 7, 2024
in Breaking News
0
Neurotechnology
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On February 6, 2024, Patrick Cunningham, an analyst at Citigroup, expressed his positive sentiment towards Eastman Chemical (NYSE:EMN) by maintaining a Buy rating on the stock. Although he adjusted the price target from $96 to $95, this modification does not diminish his optimistic outlook on the company. Cunningham’s consistent recommendation to Buy EMN shares further reinforces his bullish stance. The consensus target price for Eastman Chemical stands at $96.56, indicating an outperform rating. The stock also boasts a high price target of $130 and a low price target of $78.

EMN Stock: Mixed Performance with After-Hours Drop on February 6, 2024

On February 6, 2024, EMN stock, the ticker symbol for Eastman Chemical Company, experienced mixed performance throughout the day. EMN stock was trading in the middle of its 52-week range on that day and near its 200-day simple moving average, indicating that the stock’s price was in line with its long-term trend. The price of EMN shares saw a slight increase of $0.08 since the market last closed on February 5, 2024, bringing the closing price of EMN stock to $82.61. However, after the market closed, EMN stock experienced a drop of $0.63 in after-hours trading. This drop in price during after-hours trading suggests that there may have been some negative news or market sentiment surrounding EMN, leading to a decline in its value. It is important to note that after-hours trading can be more volatile and have lower liquidity compared to regular trading hours. Investors and analysts closely monitor after-hours trading to gauge the market’s reaction to news releases, earnings reports, or other significant events that occur outside regular trading hours. In conclusion, on February 6, 2024, EMN stock showed mixed performance, with a slight increase during regular trading hours and a decline in after-hours trading.

Eastman Chemical Company (EMN) Demonstrates Steady Financial Performance in the Stock Market

On February 6, 2024, Eastman Chemical Company (EMN) displayed a steady performance in the stock market. The company’s financial data reveals that EMN has maintained consistent figures in terms of total revenue, net income, and earnings per share. EMN reported a total revenue of $9.21 billion over the past year, which is a decrease of 12.58% compared to the previous year. However, the company’s total revenue remained flat since the last quarter. EMN recorded a net income of $894 million over the past year, representing an increase of 12.74% compared to the previous year. Similar to the total revenue, the net income held flat since the last quarter. The earnings per share (EPS) for EMN stood at $7.49 over the past year, displaying an increase of 17.97% compared to the previous year. However, the EPS witnessed a significant surge of 74.49% since the last quarter. Overall, EMN’s stock performance on February 6, 2024, showcased stability and consistency in its financial metrics. Investors and analysts will likely analyze these figures to evaluate EMN’s performance and make informed decisions regarding their investments.

Tags: EMN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Cup of coffee

Revolutionizing Sports Streaming Disney Warner Bros and Fox Join Forces

Radio telecommunications

Gina Carano Files Lawsuit Against Disney and Lucasfilm Implications for the Entertainment Industry

GLPIs Acquisition of Tioga Downs Casino Resort A Path to Growth and Success

Recommended

Lockheed Stock

Lockheed Martin Secures Landmark $9.8 Billion Missile Contract Amid Market Pressures

2 weeks ago

Gladstone Land Corporations Successful Sale of Florida Farm Demonstrates Investment Prowess

2 years ago
Real Estate Investment Trading online

Needham Analyst Reiterates Buy Rating and 63 Price Target for Uber Technologies

2 years ago
Finance_Budgeting (1)

Investors Bullish on Celsius Holdings Options Trades and Price Range Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intel’s Nvidia Partnership Sparks Market Uncertainty

Immunocore Shares Face Technical Pressure Despite Solid Fundamentals

Opendoor Announces Sudden Departure of Finance Chief Amid Leadership Reshuffle

First Commonwealth Stock: A Clash of Convictions Between Insiders and Institutions

Palantir Secures Landmark UK Defense Contract in Major Market Move

Alphabet’s Regulatory Crossroads: AI Ambitions Clash With Antitrust Threats

Trending

Salesforce Stock
AI & Quantum Computing

Salesforce Leadership’s Stock Sales Raise Investor Concerns

by Andreas Sommer
September 22, 2025
0

Salesforce CEO Marc Benioff has significantly accelerated his selling of company shares in recent weeks, with his...

Viking Therapeutics Stock

Viking Therapeutics Approaches Critical Market Inflection Point

September 22, 2025
Uranium Energy Stock

Uranium Energy Faces Investor Scrutiny Following Critical Short Report

September 22, 2025
Intel Stock

Intel’s Nvidia Partnership Sparks Market Uncertainty

September 22, 2025
Immunocore Holdings Stock

Immunocore Shares Face Technical Pressure Despite Solid Fundamentals

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Salesforce Leadership’s Stock Sales Raise Investor Concerns
  • Viking Therapeutics Approaches Critical Market Inflection Point
  • Uranium Energy Faces Investor Scrutiny Following Critical Short Report

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com